Generative AI in Healthcare Market Analysis

  • Report ID: 5728
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Generative AI in Healthcare Market Analysis

Application (Clinical, System)

Based on application, the clinical segment in the generative AI in healthcare market is projected to hold the largest share of about 60% during the forecast period. Because generative AI is being integrated into specialist fields like cancer, infectious disease, dermatology, and cardiovascular care, this market segment has become a dominant force in the healthcare industry. Advanced cardiac data analysis is one way that generative AI is being used in cardiovascular health to support accurate diagnosis and individualized therapy planning. By examining skin issues, dermatology can provide more precise diagnosis and therapy recommendations. Generative AI aids in the identification of pathogens and facilitates quick reactions to outbreaks of infectious diseases. It is essential for genetic analysis and tailored treatment recommendations in oncology, demonstrating the substantial influence of generative AI in improving clinical decision-making. Globally, cardiovascular diseases (CVDs) account for 17.9 million deaths annually, making them the leading cause of death.

Component (Solutions, Service)

Based on the component, the solution segment in the generative AI in healthcare market is predicted to hold the largest share of about 58% during the forecast period. Code generation uses machine learning models to generate code automatically. A rapidly developing field, generative AI has several potential uses in the medical field, such as drug development, predictive modeling, and improved medical imaging. A given solution segment's prospective domination would probably result from its shown efficacy, affordability, regulatory compliance, and smooth integration into the current healthcare infrastructures. Better diagnostic results, faster drug development, and more accurate patient care are some of the factors that could lead to a particular generative AI system dominating the healthcare sector.

Our in-depth analysis of the global market includes the following segments:

         Component

  • Solutions
  • Service

          Application

  • Clinical
  • System

          Function

  • Personalized Treatment Plans
  • Virtual Patient Assistance
  • Patient Monitoring & Predictive Analytics
  • Medical Image Analysis & Diagnostics
  • Drug Discovery & Development

          End-Use

  • Healthcare Providers
  • Pharmaceutical & Life Science Companies
  • Healthcare Payers
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5728
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of generative AI in healthcare is assessed at USD 2.93 billion.

Generative AI in Healthcare Market size was valued at USD 2.33 billion in 2024 and is set to reach USD 89.52 billion by the end of 2037, registering around 32.4% CAGR during the forecast period i.e., between 2025-2037. The application of generative AI in medication research and development will drive the market growth.

North America industry is estimated to hold largest revenue share of 34% by 2037, impelled by cutting-edge AI technologies in the region.

The major players in the market are Oracle Corporation, NVIDIA Corporation, Google LLC, Epic Systems Corporation, Syntegra Medical Mind, Insilico Medicine, IBM Watson Health Corporation, Abridge AI Inc., DiagnaMed Holdings Corp., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample